Van Buijtenen, VP of Human Nutrition and Health at DSM Nutritional Products Europe, said a major concern is that the regulation is stifling innovation.
Another challenge is the lack of transparency in submission guidelines, he said, adding that EFSA should stop publishing opinions until clarification is achieved.
Baldwin, senior scientific and regulatory consultant at Cantox Health Sciences International, delved into the detail of health claim submissions and highlighted areas where companies could be going wrong – and right.